31 results on '"Vencovský, Jiří"'
Search Results
2. Discovery of new myositis genetic associations through leveraging other immune-mediated diseases
3. Autoantibodies and damage in patients with idiopathic inflammatory myopathies: A longitudinal multicenter study from the MYONET international network
4. Effect modification of cancer on the association between dysphagia and mortality in early idiopathic inflammatory myopathies
5. Patient-reported outcomes in axial spondyloarthritis and psoriatic arthritis patients treated with secukinumab for 24 months in daily clinical practice
6. Patient global assessment and inflammatory markers in patients with idiopathic inflammatory myopathies – A longitudinal study
7. Differences and similarities between the EULAR/ASAS-EULAR and national recommendations for treatment of patients with psoriatic arthritis and axial spondyloarthritis across Europe
8. Distinct HLA associations with autoantibody-defined subgroups in idiopathic inflammatory myopathies
9. Environmental and societal factors associated with COVID-19-related death in people with rheumatic disease: an observational study
10. Outcomes of COVID-19 in patients with primary systemic vasculitis or polymyalgia rheumatica from the COVID-19 Global Rheumatology Alliance physician registry: a retrospective cohort study
11. The pre-clinical phase of rheumatoid arthritis: From risk factors to prevention of arthritis
12. Interleukin-35 in idiopathic inflammatory myopathies
13. Idiopathic Inflammatory Myopathies
14. Pro-inflammatory S100A11 is elevated in inflammatory myopathies and reflects disease activity and extramuscular manifestations in myositis
15. Interleukin-20 is triggered by TLR ligands and associates with disease activity in patients with rheumatoid arthritis
16. Anti-HMGCR antibodies as a biomarker for immune-mediated necrotizing myopathies: A history of statins and experience from a large international multi-center study
17. Pro-inflammatory effects of interleukin-35 in rheumatoid arthritis
18. 130 Low Gene Copy Numbers (GCN) of complement C4 and C4A deficiency are highly significant genetic risk factors for idiopathic inflammatory myopathies and its major subgroups
19. The effects of the spleen tyrosine kinase inhibitor fostamatinib on ambulatory blood pressure in patients with active rheumatoid arthritis: results of the OSKIRA-ABPM (ambulatory blood pressure monitoring) randomized trial
20. The level of fatty acid-binding protein 4, a novel adipokine, is increased in rheumatoid arthritis and correlates with serum cholesterol levels
21. The level of serum visfatin (PBEF) is associated with total number of B cells in patients with rheumatoid arthritis and decreases following B cell depletion therapy
22. Increased serum concentration of immune cell derived microparticles in polymyositis/dermatomyositis
23. Treatment-resistant inflammatory myopathy
24. Prospective new biological therapies for rheumatoid arthritis
25. 255th ENMC workshop: Muscle imaging in idiopathic inflammatory myopathies. 15th January, 16th January and 22nd January 2021 – virtual meeting and hybrid meeting on 9th and 19th September 2022 in Hoofddorp, The Netherlands
26. Therapeutic strategies in polymyositis and dermatomyositis
27. 119th ENMC international workshop: Trial design in adult idiopathic inflammatory myopathies, with the exception of inclusion body myositis, 10–12 October 2003, Naarden, The Netherlands
28. 256th ENMC international workshop: Myositis specific and associated autoantibodies (MSA-ab): Amsterdam, The Netherlands, 8-10 October 2021
29. 239th ENMC International Workshop: Classification of dermatomyositis, Amsterdam, the Netherlands, 14–16 December 2018
30. Adiponectin relation to skin changes and dyslipidemia in systemic sclerosis
31. Idiopathic inflammatory myopathies – potential role of the immunoexpression of interleukin-35 in muscle biopsy and peripheral blood mononuclear cells
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.